Pierre-Alain Ruffieux

Pierre-Alain Ruffieux, PhD, is group executive, Bioprocess, at Cytiva

Articles by Pierre-Alain Ruffieux

Q&A: Cytiva’s Pierre-Alain Ruffieux on Scaling Cell and Gene Therapy Manufacturing for Global Access

June 17th 2026

Cytiva’s Pierre-Alain Ruffieux discusses standardization, regionalization, talent gaps, and regulatory pathways shaping advanced biomanufacturing’s future ahead of BIO 2026.

Latest Updated Articles

Q&A: Cytiva’s Pierre-Alain Ruffieux on Scaling Cell and Gene Therapy Manufacturing for Global Access
June 17th 2026

Pierre-Alain Ruffieux

Articles by Pierre-Alain Ruffieux

Q&A: Cytiva’s Pierre-Alain Ruffieux on Scaling Cell and Gene Therapy Manufacturing for Global Access

Latest Updated Articles

Trending on BioPharm International

Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid

Lilly's Mirikizumab (Omvoh) Hits New IBD Remission Goals

Shift to In Vivo CAR T Will Reshape Facility Design, Says Arcadis’ Emily Heffernan

The BioPharm Brief: New Approvals, Biosimilar Competition, and Deeper Remission

FDA Grants Marengo’s Invikafusp Alfa Second Fast Track Designation in TMB-H Solid Tumors